Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | IL-1 alpha | 100 | ng/mL | 3 | MIP-1A | 370.5 | 56 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1A | 213.0 | 77 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | MIP-1A | 129.0 | 73 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIP-1A | 221.0 | 55 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | MIP-1A | 225.5 | 50 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 56.0 | 67 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 61.0 | 66 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 43.0 | 62 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 57.5 | 62 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 56.0 | 71 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 57.0 | 96 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 50.0 | 68 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 60.0 | 77 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 70.5 | 68 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | MIP-1A | 76.0 | 58 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 76.5 | 82 | |
N2759 | TNF-a | 100 | ng/mL | 3 | MIP-1A | 84.0 | 58 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 76.0 | 67 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | MIP-1A | 72.0 | 74 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 82.0 | 59 | |
N2586 | TNF-a | 100 | ng/mL | 3 | MIP-1A | 95.0 | 49 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIP-1A | 21.5 | 56 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | MIP-1A | 18.0 | 60 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIP-1A | 20.0 | 50 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | MIP-1A | 18.0 | 68 |